According to Aidar Ishmukhametov, the center filed an application with the WHO for CoviVac’s assessment and its subsequent inclusion in the EUL in April 2021
6 May in 12:40
Russia’s Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences has proved the efficacy of its polio vaccine against the novel coronavirus, the Center’s director, Aidar Ishmukhametov, said. We inoculated volunteers with a live polio vaccine and observed a dramatic slump in [coronavirus] incidence in this group. We have proved that, he said in an interview with the Vesti daily news roundup on the Rossiya-1 television channel. So far, we have left aside this matter [the efficacy of a polio vaccination as an anti-Covid measure] as, so to say, an emergency option, TASS cited him as saying.